Cargando…
Blood platelets and serum VEGF in cancer patients
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362208/ https://www.ncbi.nlm.nih.gov/pubmed/9888483 http://dx.doi.org/10.1038/sj.bjc.6690059 |
Ejemplares similares
-
Platelets and VEGF blood levels in cancer patients
por: Gunsilius, E, et al.
Publicado: (1999) -
Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients
por: Salgado, R, et al.
Publicado: (1999) -
VEGF-A165 is the predominant VEGF-A isoform in platelets, while VEGF-A121 is abundant in serum and plasma from healthy individuals
por: Yamakuchi, Munekazu, et al.
Publicado: (2023) -
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw
por: Vincenzi, Bruno, et al.
Publicado: (2012) -
Antiplatelet drugs block platelet activation by VITT patient serum
por: Smith, Christopher W., et al.
Publicado: (2021)